Collect

NASAL swab.  This is currently the only COVID-19 test we perform that does NOT require nasopharyngeal specimen collection.  Use Puritan Foam Tipped Swab.  These are available from the lab and will be kept in a designated area on each unit.

Specimen Preparation

  1. Once collected, place the swab with specimen back into the original wrapper it came in. The wrapper will serve as specimen container for transport
  2. Place Cerner label on the outside of the swab wrapper (only)
  3. Document the TIME of collection on the Cerner label, to the right of the barcode
  4. Place the labeled wrapper with the specimen in a biohazard bag, and make sure it is well sealed (since it is a dry specimen, only 1 biohazard bag is needed)
  5. Sample must be hand delivered to lab within 1 hour (NEVER send via the tube system)

Unacceptable Conditions

Mislabeled or improperly transported/handled

Stability (from collection to initiation)

1 hour at room temperature (15-30oC)

Cerner Orderable(s)

COVID 19 (Rapid)

Performed

Hospital laboratory or Ambulatory Surgery Center as appropriate

Turn around time is usually 1-2 hours

Ordering Recommendations

  • Patients who are symptomatic and/or meet criteria for testing
  • L&D
  • Elective surgery (scheduled within 24 hours)

Methodology

Abbott Rapid Test System.  This assay is based on isothermal nucleic acid amplification and targets a unique region of the RdRp segment of the SARS-CoV-2 virus

This assay is approved by the FDA as EUA (Emergency Use Authorization)

Synonyms

  • Coronavirus
  • SARS-CoV-2

Reference Interval

Negative

Interpretive Data

This test is for the detection of SARS-CoV-2 Coronavirus that causes the respiratory disease COVID-19.

A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.

A Negative test result indicates that SARS-CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history. 

An Invalid result indicates an inadequate specimen or incomplete detection of targets.  Specimen recollection is required.

The test was performed with a rapid CLIA-waived molecular assay with FDA Emergency Use Authorization (EUA), utilizing isothermal amplification of SARS-CoV-2 genomic sequences.  The test was verified and conducted within the BayCare Health System Laboratories.

 

Collection

Collect

NASAL swab.  This is currently the only COVID-19 test we perform that does NOT require nasopharyngeal specimen collection.  Use Puritan Foam Tipped Swab.  These are available from the lab and will be kept in a designated area on each unit.

Specimen Preparation

  1. Once collected, place the swab with specimen back into the original wrapper it came in. The wrapper will serve as specimen container for transport
  2. Place Cerner label on the outside of the swab wrapper (only)
  3. Document the TIME of collection on the Cerner label, to the right of the barcode
  4. Place the labeled wrapper with the specimen in a biohazard bag, and make sure it is well sealed (since it is a dry specimen, only 1 biohazard bag is needed)
  5. Sample must be hand delivered to lab within 1 hour (NEVER send via the tube system)

Unacceptable Conditions

Mislabeled or improperly transported/handled

Stability (from collection to initiation)

1 hour at room temperature (15-30oC)
Ordering

Cerner Orderable(s)

COVID 19 (Rapid)

Performed

Hospital laboratory or Ambulatory Surgery Center as appropriate

Turn around time is usually 1-2 hours

Ordering Recommendations

  • Patients who are symptomatic and/or meet criteria for testing
  • L&D
  • Elective surgery (scheduled within 24 hours)

Methodology

Abbott Rapid Test System.  This assay is based on isothermal nucleic acid amplification and targets a unique region of the RdRp segment of the SARS-CoV-2 virus

This assay is approved by the FDA as EUA (Emergency Use Authorization)

Synonyms

  • Coronavirus
  • SARS-CoV-2
Result Interpretation

Reference Interval

Negative

Interpretive Data

This test is for the detection of SARS-CoV-2 Coronavirus that causes the respiratory disease COVID-19.

A Positive result indicates that RNA from SARS-CoV-2 (formerly 2019-nCoV) was detected, and that the patient is considered infected with the virus and presumed to be contagious.

A Negative test result indicates that SARS-CoV-2 RNA was not detected. Negative results should be interpreted in combination with clinical observations and patient history. 

An Invalid result indicates an inadequate specimen or incomplete detection of targets.  Specimen recollection is required.

The test was performed with a rapid CLIA-waived molecular assay with FDA Emergency Use Authorization (EUA), utilizing isothermal amplification of SARS-CoV-2 genomic sequences.  The test was verified and conducted within the BayCare Health System Laboratories.

 

Administrative